Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Girish Ranadive
Introduction
Girish Ranadive is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of biochemistry, particularly in the modification of monoclonal antibodies. His work has implications for various applications in medical and pharmaceutical research.
Latest Patents
Girish holds a patent for a method titled "Regioselective chemical modification of monoclonal antibodies." This innovative method involves selectively modifying an immunoglobulin that has at least one Fab region and one Fc region. The process is characterized by modifying the immunoglobulin at a pH between the respective isoelectric points of the Fab and Fc fragments, which allows for precise alterations in the antibody's properties. He has 1 patent to his name.
Career Highlights
Girish is affiliated with the University of Pittsburgh, where he conducts research and develops new methodologies in the field of immunology. His academic background and ongoing research contribute to advancements in therapeutic applications of antibodies.
Collaborations
Girish has collaborated with esteemed colleagues such as Howard S. Rosenzweig and Michael Wayne Epperly. These partnerships enhance the scope and impact of his research endeavors.
Conclusion
Girish Ranadive's innovative work in the modification of monoclonal antibodies showcases his commitment to advancing biochemistry. His contributions are vital for the development of new therapeutic strategies in medicine.